The Ministry of Health (MoH) has ordered the withdrawal of Batch No. 517999 of Augmentin 250 mg for children, made by GlaxoSmithKline (GSK), from all public and private hospitals, medical centers, clinics and pharmacies as tiny plastic pieces could mix with the medicine due to a manufacturing failure. In a statement issued today, MoH's Assistant Undersecretary for Medical Practices and Licensing Dr Amin Hussein Al Amiri said the circular issued today by the Ministry also bans further imports of the same batch and orders GSK to provide a detailed report on the withdrawal of the drug and to provide enough quantities to make up for any possible shortage. All other batches of the said product are safe for human consumption and any side effects which might develop should however be reported online to the ministry, the official said.
GMT 10:31 2018 Tuesday ,13 November
Russian police uproot 70 underground drug labs in past six monthsGMT 16:32 2018 Tuesday ,06 November
Rwanda aims to achieve universal access to clean water by 2024GMT 16:57 2018 Sunday ,04 November
Palestinian women witness higher cure rate of breast cancerGMT 13:11 2018 Tuesday ,30 October
Emergency surgery saves life of touristGMT 10:44 2018 Tuesday ,23 October
Scientists find microplastics in human stool for first timeGMT 09:18 2018 Tuesday ,23 October
US judge upholds Monsanto weedkiller cancer verdict, reduces payoutGMT 14:22 2018 Friday ,19 October
Birth spacing ‘improving health of Omani women’GMT 15:40 2018 Monday ,15 October
Pakistani president launches nationwide anti-measles driveMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor